The Cancer Letter Archives
The Cancer Letter was founded in 1973, two years after Congress passed the National Cancer Act of 1971. These archives represent the first 40 years of The Cancer Letter, which is published weekly.
TCL
Vol.
26
No.
09
March 03, 2000
- Judge Invalidates Bristol-Myers’ Claims For The Administration Of Taxol.
- Larry Norton Is President-Elect Of ASCO; Rauscher Is Cancer Research Editor-In-Chief.
- Sharp To Direct New Institute For Brain Research At MIT.
- Report From The Front Lines In War On Cancer Past, Present.
- NIEHS Uses Gene Chips To Evaluate Chemicals.
TCL
Vol.
26
No.
10
March 10, 2000
- Sponsors Wanted: FDA Offers Incentives For Pediatric Oncology Drug Development.
- March Dedicated To Colorectal Cancer Awareness; New Advocacy Group.
- NCI Plans Progress Review In Lymphoma This Year.
- Project Expands Group Studies To Community Oncologists.
- Agencies Announce Plans To Monitor Gene Therapy Trials.
TCL
Vol.
26
No.
11
March 17, 2000
- Bush Says National Dialogue On Cancer Needs To Correct Problems And Move On.
- Haller Named Editor-In-Chief Of JCO; White House Appoints Duffy To NCAB.
- NCCS Appointment Marks Transition To New Structure.
- University Fires Bezwoda For Scientific Misconduct.
- Gene Expression Data Posted On Web For Research Use.
TCL
Vol.
26
No.
13
March 31, 2000
- Advisors Approve NCI Plan To Contract For Early Clinical Trials Of Imaging Agents.
- NCI Recruits Carl Barrett Of NIEHS To Direct Basic Sciences; Freedman named to NCAB.
- Sieber Direct Communications At NCI, Reorganizing Offices.
- “5 A Day” Review Underway to Check Program’s Health at NCI.
- AACR Honors Nine Cancer Researchers, Clinicians.
- Cytogen Corp.’s Imaging Agent ProstaScint Added to NCCN Prostate Cancer Guidelines.
- FDA Grants Six-Month Priority Review To Nolvadex For DCIS Adjuvant Treatment.
- Bristol-Myers, Karolinska In Collaboration For Studies.
- Antigenics Begins Phase II Trial Of Oncophage for NHL.
- Aphton To Test Anti-Gastrin Drug At M. D. Anderson. NAS
- RFP: Intellectual Property.
